by Caroline Fife, M.D. | Feb 26, 2025 | Medicare Audits
Here’s another fantastic post from attorney Knicole Emanuel about the serious overreach problems inside the alphabet soup of Medicare audits. This is an issue that will get even more problematic due to the delay of the “skin substitute” LCD(s). Some auditors are...
by Caroline Fife, M.D. | Feb 24, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitute Arrests
Check out Jeanne Pinder’s latest article about skin substitutes on Clear Health Costs! Caroline Fife, M.D.Dr. Fife is a world renowned wound care physician dedicated to improving patient outcomes through quality driven care. Please visit my blog...
by Caroline Fife, M.D. | Feb 21, 2025 | Pyoderma Gangrenosum
Check out this fantastic review article about pyoderma gangrenosum (PG) by Dr. Alex Loayza and colleagues from the Oregon Health and Science University’s Department of Dermatology. Dr. Loayza has been incredibly generous with his time and expertise when wound care...
by Caroline Fife, M.D. | Feb 19, 2025 | Fight the Good Fight
Some of you have alerted me to new taxonomy codes that are relevant to the practice of wound care. This seems like huge news to me! I am listing a few of them below, with some explanation of what the components of the code mean. I do not know, for example, if an...
by Caroline Fife, M.D. | Feb 17, 2025 | Fight the Good Fight, Miscellaneous Musings
The AP (2/7, Stobbe) reported, “The U.S. winter virus season is in full force, and by one measure is the most intense in 15 years.” According to the AP, “one indicator of flu activity is the percentage of doctor’s office visits driven by flu-like symptoms.” Two weeks...
by Caroline Fife, M.D. | Feb 14, 2025 | Fight the Good Fight
On January 30th, the U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting a pain-signaling pathway...
by Caroline Fife, M.D. | Feb 12, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
EDIT: Thank you to the medical sales rep who sent me my smile for the day with this message. “Would love to apply but the apply button does not work. Former [redacted] employee and medical equipment rep. Let me know or send me a link.” Thank you...
by Caroline Fife, M.D. | Feb 11, 2025 | Fight the Good Fight, Healthcare Payment Policy, Medicare Audits
The Alliance of Wound Care Stakeholders is hosting a webinar on Wednesday, February 12, 2025, 1:00 PM – 2:00 PM EST. If you and your organization provide wound care to Medicare beneficiaries, are you prepared for the important policy updates for 2025 implemented by...
by Caroline Fife, M.D. | Feb 10, 2025 | Fight the Good Fight
JAMA has just published the results of the WHIST Randomized Clinical Trial, Effect of Incisional Negative Pressure Wound Therapy vs Standard Wound Dressing on Deep Surgical Site Infection After Surgery for Lower Limb Fractures Associated With Major Trauma. You should...
by Caroline Fife, M.D. | Feb 5, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
Skin substitutes and possible danger: Is patient harm happening in wound care? Jeanne Pinder from Clear Health Costs has posted a powerful follow up article on the use of Cellular Tissue Products (CTPs) / skin substitutes. Ms. Pinder interviewed Dr. Danielle...
